HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shunji Yamazaki Selected Research

Immunophilins

6/2012FK1706, a novel non-immunosuppressive immunophilin ligand, modifies gene expression in the dorsal root ganglia during painful diabetic neuropathy.
12/2008FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy.
9/2008FK1706, a novel non-immunosuppressant neurophilin ligand, ameliorates motor dysfunction following spinal cord injury through its neuroregenerative action.
2/2005FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shunji Yamazaki Research Topics

Disease

2Non-alcoholic Fatty Liver Disease
05/2015 - 12/2012
2Diabetic Neuropathies (Diabetic Neuropathy)
06/2012 - 12/2008
2Hyperalgesia
06/2012 - 12/2008
2Memory Disorders (Memory Loss)
12/2005 - 10/2002
2Dementia (Dementias)
12/2005 - 10/2002
1Arthritis (Polyarthritis)
01/2017
1Rheumatoid Arthritis
01/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Obesity
05/2015
1Metabolic Diseases (Metabolic Disease)
05/2015
1Type 2 Diabetes Mellitus (MODY)
05/2015
1Fibrosis (Cirrhosis)
05/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2015
1Inflammation (Inflammations)
05/2015
1Pain (Aches)
06/2012
1Spinal Cord Injuries (Spinal Cord Injury)
09/2008
1Wounds and Injuries (Trauma)
09/2008
1Contusions
09/2008
1Parkinson Disease (Parkinson's Disease)
03/2007
1Brain Ischemia (Cerebral Ischemia)
03/2007
1Brain Injuries (Brain Injury)
03/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2007
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2007
1Stroke (Strokes)
03/2007
1Alzheimer Disease (Alzheimer's Disease)
12/2005
1Cognitive Dysfunction
12/2005
1Nervous System Diseases (Neurological Disorders)
02/2005

Drug/Important Bio-Agent (IBA)

4FK1706IBA
06/2012 - 02/2005
4LigandsIBA
06/2012 - 02/2005
4ImmunophilinsIBA
06/2012 - 02/2005
2Pharmaceutical PreparationsIBA
12/2012 - 10/2002
2Streptozocin (Streptozotocin)FDA Link
06/2012 - 12/2008
2Glucose (Dextrose)FDA LinkGeneric
06/2012 - 12/2008
2N-(4-acetyl-1-piperazinyl) -4-fluorobenzamide monohydrateIBA
12/2005 - 10/2002
2Scopolamine (Hyoscine)FDA Link
12/2005 - 10/2002
1peficitinibIBA
01/2017
1Janus Kinase InhibitorsIBA
01/2017
1Pioglitazone (Actos)FDA Link
05/2015
1Sodium-Glucose Transporter 2 InhibitorsIBA
05/2015
1Amino AcidsFDA Link
05/2015
1Triglycerides (Triacylglycerol)IBA
05/2015
1CDAA (Randox)IBA
05/2015
1Choline (Choline Chloride)IBA
05/2015
1Hydroxyproline (4 Hydroxyproline)IBA
05/2015
1ipragliflozinIBA
05/2015
1Biomarkers (Surrogate Marker)IBA
12/2012
1Gabapentin (Neurontin)FDA LinkGeneric
12/2008
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2008
1Nerve Growth Factor (NGF)IBA
09/2008
14- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA
03/2007
1Cytotoxins (Cytolysins)IBA
03/2007
1Acetic Acid (Vinegar)FDA LinkGeneric
03/2007
1GW 501516IBA
03/2007
1PPAR deltaIBA
03/2007
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2007
1N- (1- acetylpiperidin- 4- yl)- 4- fluorobenzamideIBA
12/2005
1Nootropic Agents (Nootropics)IBA
12/2005
1Donepezil (Aricept)FDA LinkGeneric
10/2002

Therapy/Procedure

1Oral Administration
06/2012